Clinical Trials List
2021-10-21 - 2022-11-15
Phase III
Not yet recruiting5
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Fu Ouyang Division of General Surgery
- 巫承哲 Division of General Surgery
- 張智皓 Division of General Surgery
- Chieh-Han Chuang Division of General Surgery
- 高理鈞 Division of General Surgery
- 高捷妮 Division of General Surgery
- 甘蓉瑜 Division of General Surgery
- Junping Shiau Shiau Division of General Surgery
- Ming-Feng Hou Division of General Surgery
- Shen Liang Shih Division of General Surgery
- Chung-Liang Li Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Shang-Hung Chen Division of General Surgery
- Chun-Hui Lee Division of General Surgery
- Zhu-Jun Loh Division of General Surgery
- 楊舜如 Division of General Surgery
- Jui-Hung Tsai Division of General Surgery
- Yao-Lung Kuo Division of General Surgery
- Wei-Pang Chung Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Yi-Fang Tsai Division of General Surgery
- Jiun-I Lai Division of General Surgery
- Chi-Cheng Huang Division of General Surgery
- Chun-Yu Liu Division of General Surgery
- 邱仁輝 Division of General Surgery
- 林燕淑 Division of General Surgery
- 賴亦貞 Division of General Surgery
- Ta-Chung Chao Division of General Surgery
- 馮晉榮 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2 participants
-
Global
1200 participants
